ARCHIVES

FDA Approves Votrient For Soft Tissue Sarcomas

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002